SaaS-based technology platform company Seqster has announced the release of COVID-19 Compass, a new module built into the Seqster interoperability platform that will allow healthcare enterprises to remotely and seamlessly track the health of research subjects who may have been exposed to COVID-19.
COVID-19 Compass is based on CDC guidelines, best clinical practices, illness severity, and risk factors such as age, gender, location, potential exposure, and pre-existing health conditions.
Patients on the Seqster platform can share key health metrics related to COVID-19, such as body temperature, heart rate, and pulse oximetry that are already synced with devices connected to their Seqster profile, and can self-report additional information including symptoms of COVID-19 such as shortness of breath, fatigue, and coughing.
Research subjects are provided with official recommendations based on one of nine different scenarios determined by their responses.
For study managers, COVID-19 Compass allows monitoring of their subjects through Seqster in real time and allowing them to take necessary action to ensure that subjects’ health remains a top priority. Seqster logs the answer to every question asked on each run of COVID-19 Compass and uses the answers to generate statistical tables and graphs to help patients and the research community better understand the trends nationally and within geographic regions.
COVID-19 Compass can be deployed within 24 hour and is built on the cloud-based Seqster platform hosted on HIPAA-compliant and HITRUST-certified servers. The technology can scale automatically to thousands of active users and receive updated content as COVID-19 guidelines evolve.